Molecular profiling of soft-tissue sarcomas with FoundationOne
FoundationOne® Heme
complex karyotype
next-generation sequencing
soft-tissue sarcoma
targeted therapy
translocation-associated sarcoma
Journal
Therapeutic advances in medical oncology
ISSN: 1758-8340
Titre abrégé: Ther Adv Med Oncol
Pays: England
ID NLM: 101510808
Informations de publication
Date de publication:
2021
2021
Historique:
received:
07
03
2021
accepted:
11
06
2021
entrez:
9
8
2021
pubmed:
10
8
2021
medline:
10
8
2021
Statut:
epublish
Résumé
Molecular diagnosis has become an established tool in the characterisation of adult soft-tissue sarcomas (STS). FoundationOne We evaluated FoundationOne Although FoundationOne In summary, FoundationOne
Sections du résumé
BACKGROUND
BACKGROUND
Molecular diagnosis has become an established tool in the characterisation of adult soft-tissue sarcomas (STS). FoundationOne
METHODS
METHODS
We evaluated FoundationOne
RESULTS
RESULTS
Although FoundationOne
CONCLUSIONS
CONCLUSIONS
In summary, FoundationOne
Identifiants
pubmed: 34367342
doi: 10.1177/17588359211029125
pii: 10.1177_17588359211029125
pmc: PMC8317253
doi:
Types de publication
Journal Article
Langues
eng
Pagination
17588359211029125Informations de copyright
© The Author(s), 2021.
Déclaration de conflit d'intérêts
Conflict of interest statement: The authors declare that there is no conflict of interest.
Références
Lancet Oncol. 2017 Jun;18(6):812-822
pubmed: 28499583
Nat Biotechnol. 2013 Nov;31(11):1023-31
pubmed: 24142049
Nat Med. 2019 Feb;25(2):292-300
pubmed: 30664779
J Clin Oncol. 2018 Jan 10;36(2):125-135
pubmed: 29220291
Pharmacol Ther. 2019 Oct;202:149-164
pubmed: 31276706
Nat Rev Clin Oncol. 2018 May;15(5):273-291
pubmed: 29508857
Oncotarget. 2017 Jun 13;8(24):39254-39267
pubmed: 28424409
Cancer Lett. 2019 Aug 28;458:56-65
pubmed: 31128216
J Orthop Sci. 2017 Jul;22(4):601-612
pubmed: 28274512
Cancer Res. 2015 Sep 15;75(18):3823-31
pubmed: 26183925
Mod Pathol. 2018 Nov;31(11):1683-1693
pubmed: 29955147
Mod Pathol. 2010 Oct;23(10):1379-92
pubmed: 20639860
Mol Aspects Med. 2020 Apr;72:100827
pubmed: 31703948
N Engl J Med. 2019 May 16;380(20):1929-1940
pubmed: 31091374
Histopathology. 2014 Jan;64(1):2-11
pubmed: 24164390
Genome Res. 2018 Nov;28(11):1747-1756
pubmed: 30341162
Ther Adv Med Oncol. 2011 Nov;3(1 Suppl):S7-S19
pubmed: 22128289
Int J Cancer. 2019 Aug 15;145(4):1148-1161
pubmed: 30779112
Lancet Oncol. 2020 Feb;21(2):271-282
pubmed: 31838007
Cell Rep. 2019 Sep 10;28(11):2837-2850.e5
pubmed: 31509746
Ann Surg Oncol. 2012 Aug;19(8):2716-25
pubmed: 22476749
Oncotarget. 2018 Jan 19;9(12):10549-10560
pubmed: 29535826
Lancet Oncol. 2016 May;17(5):671-80
pubmed: 27068860
Clin Sarcoma Res. 2019 Sep 11;9:12
pubmed: 31528332
Cell. 2017 Nov 2;171(4):950-965.e28
pubmed: 29100075
Mod Pathol. 2021 Feb;34(2):396-407
pubmed: 32860002
JAMA Oncol. 2018 Oct 1;4(10):1398-1404
pubmed: 29801054
Nat Rev Clin Oncol. 2020 Sep;17(9):569-587
pubmed: 32514147
Chronic Dis Transl Med. 2017 Jul 19;3(3):148-153
pubmed: 29063069
Genes Chromosomes Cancer. 2018 Dec;57(12):611-621
pubmed: 30276917
Diagn Pathol. 2018 Aug 21;13(1):56
pubmed: 30126419
N Engl J Med. 2018 Feb 22;378(8):731-739
pubmed: 29466156
Mod Pathol. 2007 Mar;20(3):397-404
pubmed: 17334332
JCO Precis Oncol. 2019;2019:
pubmed: 30793095
J Thorac Oncol. 2019 May;14(5):825-834
pubmed: 30550870
Arch Pathol Lab Med. 2006 Oct;130(10):1448-53
pubmed: 17090186
JAMA Oncol. 2016 Jul 1;2(7):937-40
pubmed: 27124835
Nat Med. 2014 Dec;20(12):1479-84
pubmed: 25384085
Nat Genet. 2010 Aug;42(8):715-21
pubmed: 20601955
Cancers (Basel). 2020 Dec 03;12(12):
pubmed: 33287361
Int J Mol Sci. 2020 Jun 24;21(12):
pubmed: 32599895
Hum Pathol. 2019 Apr;86:57-65
pubmed: 30633925
Lancet Oncol. 2020 Apr;21(4):531-540
pubmed: 32105622
Mod Pathol. 2012 Feb;25(2):212-21
pubmed: 22020193
PLoS Genet. 2019 Apr 10;15(4):e1008039
pubmed: 30970016
Mol Cancer Ther. 2019 Apr;18(4):834-844
pubmed: 30787173
Int J Mol Sci. 2020 Apr 24;21(8):
pubmed: 32344731